Cargando…

A Further Step Toward Meaningful Trial Outcomes for Patients with Pulmonary Arterial Hypertension: Minimal Important Difference in 6-minute-walk Distance

Detalles Bibliográficos
Autor principal:	Ulrich, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2023
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112456/ https://www.ncbi.nlm.nih.gov/pubmed/36790379 http://dx.doi.org/10.1164/rccm.202301-0143ED

Ejemplares similares

Informed consent process: A step further towards making it meaningful!
por: Kadam, Rashmi Ashish
Publicado: (2017)

Remote 6-minute-Walk Testing in Patients with Pulmonary Hypertension: Further Validation Needed?
por: Helgeson, Scott A., et al.
Publicado: (2022)

Maximal Cardiac Output Determines 6 Minutes Walking Distance in Pulmonary Hypertension
por: Deboeck, Gaël, et al.
Publicado: (2014)

The need to move from 6-minute walk distance to outcome trials in pulmonary arterial hypertension
por: Gaine, Sean, et al.
Publicado: (2013)

Fick principle and exercise pulmonary hemodynamic determinants of the six-minute walk distance in pulmonary hypertension
por: Joseph, Phillip, et al.
Publicado: (2020)

Six-minute walk test in pulmonary arterial hypertension
por: Demir, Rengin, et al.
Publicado: (2015)

Facemasks and Walk Distance in Pulmonary Arterial Hypertension Patients
por: Helgeson, Scott A., et al.
Publicado: (2021)

Alternatives to the Six-Minute Walk Test in Pulmonary Arterial Hypertension
por: Mainguy, Vincent, et al.
Publicado: (2014)

Novel dose–response analyses of treprostinil in pulmonary arterial hypertension and its effects on six-minute walk distance and hospitalizations
por: Ramani, Gautam, et al.
Publicado: (2020)

Prognostic value of six-minute walk distance at a South American pulmonary hypertension referral center
por: Costa, Gabriela O.S., et al.
Publicado: (2020)

Reply to Helgeson et al.: Remote 6-minute-Walk Testing in Patients with Pulmonary Hypertension: Further Validation Needed?
por: LaPatra, Tess, et al.
Publicado: (2022)

Six-Minute Walk Test in Evaluation of Children with Pulmonary Arterial Hypertension
por: Zuk, Malgorzata, et al.
Publicado: (2017)

Minimal important difference and responsiveness of 2-minute walk test performance in people with COPD undergoing pulmonary rehabilitation
por: Johnston, Kylie Nicole, et al.
Publicado: (2017)

The minimal clinically important difference of six-minute walk in Asian older adults
por: Kwok, Boon Chong, et al.
Publicado: (2013)

Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial
por: Souza, Rogério, et al.
Publicado: (2018)

Clinically Meaningful Change in 6 Minute Walking Test and the Incremental Shuttle Walking Test following Coronary Artery Bypass Graft Surgery
por: Sheraz, Suman, et al.
Publicado: (2022)

Six-minute walk distance and survival time in patients with idiopathic pulmonary fibrosis in Brazil
por: Mancuzo, Eliane Viana, et al.
Publicado: (2018)

Determinants of Six-Minute Walk Distance in Idiopathic Pulmonary Fibrosis and Idiopathic Pleuroparenchymal Fibroelastosis
por: Sato, Naofumi, et al.
Publicado: (2022)

Lung function in relation to six-minute walk test in pulmonary hypertension
por: Farkhooy, Amir, et al.
Publicado: (2020)

The minimal important difference of six-minute walk test in subjects with chronic pulmonary aspergillosis treated with six-months of oral itraconazole
por: Sehgal, Inderpaul S., et al.
Publicado: (2023)

Effect of PAH Specific Therapy on Pulmonary Hemodynamics and Six-Minute Walk Distance in Portopulmonary Hypertension: A Systematic Review and Meta-Analysis
por: Faisal, Muhammad, et al.
Publicado: (2014)

Changes in six-minute walking distance during pulmonary rehabilitation in patients with COPD and in healthy subjects
por: Ben Cheikh Rejbi, Imen, et al.
Publicado: (2010)

Cardiac Effort to Compare Clinic and Remote 6-Minute Walk Testing in Pulmonary Arterial Hypertension
por: Lachant, Daniel, et al.
Publicado: (2022)

Heart rate recovery in 1 minute after the 6-minute walk test predicts adverse outcomes in pulmonary arterial hypertension
por: Rezende, Camila Farnese, et al.
Publicado: (2022)

Lack of association between six-minute walk distance and pulmonary artery pressure in patients with systemic sclerosis and cardiopulmonary symptoms
por: Namvar, Leila, et al.
Publicado: (2020)

Targeting BMPR2 Trafficking with Chaperones: An Important Step toward Precision Medicine in Pulmonary Arterial Hypertension
por: Andruska, Adam, et al.
Publicado: (2020)

Relationships Between Forced Oscillatory Impedance and 6-minute Walk Distance After Pulmonary Rehabilitation in COPD
por: Zimmermann, Sabine C, et al.
Publicado: (2020)

No Placebo Effect beyond Regression to the Mean on the Six Minute Walk Test in Pulmonary Arterial Hypertension Trials
por: Anheyer, Dennis, et al.
Publicado: (2023)

Perioperative Minimal Induction Therapy: A Further Step toward More Effective Immunosuppression in Transplantation
por: Gennarini, Alessia, et al.
Publicado: (2012)

Six minute walking distance in kyphoscoliosis patients with chronic respiratory failure
por: Karakurt, Zuhal, et al.
Publicado: (2010)

Factors associated with the 6-minute walk distance in patients with systemic sclerosis
por: Sanges, Sébastien, et al.
Publicado: (2017)

Determining the Minimal Important Change of Everyday Functioning in Dementia: Pursuing Clinical Meaningfulness
por: Dubbelman, Mark A., et al.
Publicado: (2022)

Steps Toward the Meaningful Translation of Prevention Strategies for Type 2 Diabetes
por: Cefalu, William T.
Publicado: (2012)

Persistence of the Postoperative Change in the Six-minute Walking Distance of Lung Cancer Patients with Chronic Obstructive Pulmonary Disease
por: Ogura, Ryoji, et al.
Publicado: (2021)

Factors Affecting Recovery of 6-Minute Walk Distance After Coronary Artery Bypass Grafting
por: Araki, Naoya, et al.
Publicado: (2023)

Two-Minute Step Test as a Complement to Six-Minute Walk Test in Subjects With Treated Coronary Artery Disease
por: Oliveros, María José, et al.
Publicado: (2022)

The mediating role of cytokine IL-6 on the relationship of FEV(1) upon 6-minute walk distance in chronic obstructive pulmonary disease
por: Baldi, Simonetta, et al.
Publicado: (2014)

Impaired Economy of Gait and Decreased Six-Minute Walk Distance in Parkinson's Disease
por: Katzel, Leslie I., et al.
Publicado: (2012)

Overweight-mortality paradox and impact of six-minute walk distance in lung transplantation
por: Chaikriangkrai, Kongkiat, et al.
Publicado: (2015)

An Alternative Prediction Equation for Evaluation of Six-Minute Walk Distance in Stable Coronary Artery Disease Patients
por: Lenasi, Helena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m6m0vvn6cfbj8hokd5o0eg95s9